 |
Catheter ablation of atrial fibrillation in paroxysmal/persistent atrial fibrillation |
| |
Circumferential PV ablation with proof of elimination of PV potential
S Ernst, Hamburg, Germany |
|
Circumferential PV ablation without proof of elimination of PV potential
M J Schalij (Leiden, NL) |
|
Fragmentation mapping and ablation
P Jais (Bordeaux, FR) |
|
Anticoagulation and electrophysiological procedures |
|
Recommendations of antithrombotic therapy in low risk procedures
M Brignole (Lavagna, IT) |
|
Recommendations of antithrombotic therapy in high risk procedures
M Fatemi (Brest, FR)
|
|
Conclusion
J M Almendral Garrote (Madrid, ES) |
|
Venous thrombosis or bleeding due to vascular access
V Reddy (Boston, US) |
|
Management (diagnosis and treatment) of syncope |
|
ILR-guided therapy
M Brignole (Lavagna, IT) |
|
Cardiac resynchronization therapy: controversial indications |
|
Atrial fibrillation
M Brignole (Lavagna, IT) |
|
Upgrading of right ventricle pacemakers
J-C Deharo (Marseille cedex 05, FR) |
|
Narrow QRS
C Israel (Frankfurt, DE) |
|
ICD and CRT
P Mabo (Rennes Cedex 09, FR) |
|
Endocardial versus true epicardial lead
L D Elvas (Coimbra, PT) |
|
Genetic aspects of arrhythmias: risk stratifications |
|
Inherited arrhythmias: is the ECG useful for risk stratification ?
C Wolpert (Mannheim, DE) |
|
Electrophysiological studies in inherited arrhythmias: are they useful?
P Brugada Terradellas (Brussels, BE) |
|
Is genetic testing useful for the management of patients?
DV Exner (Alberta, CA) |
|
Genetic counselling in inherited arrhythmias
L Crotti (Pavia, IT) |
|
What's new in cardiac resynchronisation therapy? |
|
Selecting heart failure patients for CRT
OA Breithardt (Erlangen, DE) |
|
Role of volumetric CT, MRI and 3D Echo in screening heart failure patients
N Ajmone Marsan (Leiden, NL) |
|
Impact of CRT on heart transplantation patients
E Gronda (Rozzano, IT) |
|
CRT in pediatric and congenital patients
M Emmel (Koeln, DE) |
|
Catheter ablation of ventricular tachycardia in structural heart disease |
|
EP substrate of ischaemic VTs
J M T De Bakker (Amsterdam, NL) |
|
Monomorphic VTs
C de Chillou (Vandoeuvre Les Nancy, FR) |
|
Epicardial ablation of VTs
E Sosa (Sao Paulo, BR) |
|
Polymorphic VTs and VFs
M Haissaguerre (Pessac, FR) |
|
Prophylactic implantable cardiac defibrillator therapy where no randomized trials exist
|
|
ICD in Brugada patients
N Sadoul (Vandoeuvre les Nancy, FR) |
|
ICD therapy in LQTS
C Napolitano (Pavia, IT)
|
|
Patient selection and cardiac resynchronisation therapy optimization
|
|
AV and VV interval optimization
J I Garcia Bolao (Pamplona, ES) |
|
Which criteria should be used for patient selection?
P Sogaard (Hellerup, DK) |
|
Inherited arrhythmogenic diseases
|
|
Long QT syndromes
H Le Marec (Nantes, FR) |
|
Brugada syndrome
J Brugada Terradellas (Barcelona, ES) |
|
Short QT syndrome
F Gaita (Asti, IT) |
|
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
S G Priori (Pavia, IT) |
|
Magnetic resonance imaging and implanted devices
|
|
Pro
R Sutton (London, GB) |
|
Con
M G Bongiorni (Pisa, IT) |
|
Pro
B Wilkoff (Cleveland, US) |
|
Con
W Irnich (Giessen, DE) |
|
Atrial fibrillation ablation - new techniques
|
|
Cryothermia
J Vogt (Bad Oeynhausen, DE) |
|
LASER
P Neuzil (Prague, CZ) |
|
Magnetic and robotic navigation.
V Reddy (Boston, US) |
|
Imaging and navigation techniques
|
|
High speed rotational angiography
V Reddy (Boston, US) |
|
Imaging integration
D M Cavaco (Lisboa, PT) |
|
Intracardiac ultrasound - ICE
S Themistoclakis (Mestre (Venice), IT) |
|
Robotic and magnetic navigation
B D Lindsay (Washington, US) |
|
Management (diagnosis and treatment) of syncope
|
|
Tilt testing
A Moya I Mitjans (Barcelona, ES) |
|
Primary prevention of sudden cardiac death: from guidelines to practice
|
|
ACC/AHA/ESC Guidelines on the prevention of SCD
E N Prystowsky (Indianapolis, US) |
|
Primary prevention of SCD: the point of view of the electrophysiologist
N A M Estes (Boston, US) |
|
Primary prevention of SCD: the point of view of the heart failure specialist
P Ponikowski (Wroclaw, PL) |
|
Heart failure and atrial fibrillation
|
|
Rate or rhythm control as first option?
HJGM Crijns (Maastricht, NL) |
|
AV junction ablation and pacing when drugs fail? CRT or conventional pacing?
S-A Chen (Taipei, TW) |
|
Health care expenditure and cost
J-Y Le Heuzey (Paris, FR) |
|
Device replacement in patients without implantable cardiac defibrillator intervention
|
|
Pro
M Gwechenberger (Wien, AT) |
|
Con
M Taborsky (Prague 5, CZ) |
|
Stem cell therapy: electrophysiological implications
|
|
Electrophysiological properties of stem-cells
U Ravens (Dresden, DE) |
|
AF and progenitor cells
A Goette (Magdeburg, DE) |
|
Sudden death and syncope
|
|
CRT is helpful in HF patients except for...
L Mont (Barcelona, ES) |
|
Post MI risk stratification is useless except for...
H V Huikuri (Oulu, FI) |
|
Pacing for syncope is useless except for...
L-I Kraemer (Koln, DE) |
|
ICD after VT ablation is not mandatory except for...
P Della Bella (Milan, IT) |
|
Sudden death - implantable cardiac defibrillator, ablation or drugs
|
|
Unstable VT/VF in organic HD with better LV function (EF>35%)
P Della Bella (Milan, IT) |
|
Stable VT in organic heart disease in patients with EF>35%
E Delacretaz (Bern, CH) |
|
Stable VT in organic heart disease in patients with <35%
G Steinbeck (Munich, DE) |
|
VT/VF in patients with poor LV-function (EF<35%), but with an acute or "reversible"cause
K Seidl (Ludwigshafen, DE) |
|
Telemonitoring
|
|
ILR in syncope - changing practice
D Andresen (Berlin, DE) |
|
Pacemaker management at home
S M Ellery (Surrey, GB) |
|
Treatment/prevention of paroxysmal atrial fibrillation
|
|
AV junctional ablation is obsolete, except for...
E Aliot (Vandoeuvre-les-Nancy, FR) |
|
Pacemaker implantation is obsolete, except for...
A J Camm (London, GB) |
|
Amiodarone is obsolete in patients under 40, except for...
P Chevalier (Lyon, FR) |
|
Catheter ablation as a first line treatment is not indicated except for...
M Fiala (Trinec, CZ) |
|
Clinical deterioration after cardiac resynchronisation therapy. What to do next?
|
|
Heart Failure Surgery
R Dion (Leiden, NL) |
|
Drugs
C Israel (Frankfurt, DE) |
|
Anticoagulation in atrial fibrillation: new concepts
|
|
Combine antiplatelet therapy in atrial fibrillation: ACTIVE W and beyond
S H Hohnloser (Frankfurt, DE) |
|
Idraparinux
G Gerotziafas (Paris, FR) |
|
Development of new antithrombin inhibitors: the RELY study
M D Ezekowitz (Wynnewood, US) |
|
Anticoagulation of atrial fibrillation after acute coronary interventions
A Laucevicius (Vilnius, LT) |
|
End-points of catheter ablation for atrial fibrillation
|
|
Radio frequency ablation of chronic atrial fibrillation: the endpoints
C Pappone (Milan, IT) |
|
Elimination of PV potentials
M Duytschaever (Ghent, BE) |
|
Non inducibility of atrial fibrillation
P Sanders (Adelaide, AU) |
|
Macroreentrant atrial tachycardia
|
|
In "normal hearts"
G Hindricks (Leipzig, DE) |
|
After mitral valve surgery
N M S De Groot (Leiden, NL) |